RareResearch.AI
← Back to atlas

P404L

Category 3/4 — Most DruggableUncertain significanceTransmembrane · predictedSource card
ProlineLeucine at position 404 · Transmembrane helix 4 · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type P404 — hydrogen bond to F408
Fullscreen ↗
DynaMut2 mutant · P404L
Mutant L404 — hydrogen bond to D367 lost (4 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

4 lost5 gained6 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondD367Lost
Hydrogen bondH401Lost
Hydrogen bondH407Gained
Hydrogen bondF408F408Preserved
Polar contactD367Gained
Polar contactH401H401Preserved
Polar contactL402Gained
Polar contactH407H407Preserved
Polar contactF408F408Preserved
Van der WaalsH401Lost
Van der WaalsL402Lost
HydrophobicK363K363Preserved
HydrophobicV364V364Preserved
HydrophobicD367Gained
HydrophobicH401Gained

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-0.58kcal/mol
Destabilising — mild
AlphaMissense
0.874
likely pathogenic
AlphaFold pLDDT
88
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationUncertain significance
Review statuscriteria provided, multiple submitters, no conflicts
Associated conditionsWolfram syndrome 1; Cataract 41; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome
Population frequency (gnomAD v4)Ultra-rare · AF 0.00087%
cDNA changec.1211C>T
ClinVar accessionVCV001378120
Last evaluated2024/11/16 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — P404L Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Proline → Leucine at position 404. Transmembrane helix 4. ClinVar Uncertain significance, AlphaMissense 0.874, DynaMut2 ΔΔG -0.58 kcal/mol (destabilising).


Identity

FieldValue
VariantP404L (p.Proline404Leucine)
DNA changec.1211C>T
Gene · ProteinWFS1 · Wolframin (890 aa)
UniProtO76024 · WFS1_HUMAN
ClinVar accessionVCV001378120
Amino acid changeProline (P) → Leucine (L)

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 40487.75 — well-folded
DomainTransmembrane helix 4
Position contextInside Transmembrane helix 4 · position 404 is bilayer-embedded
IDR flagNo — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 404 sits in a transmembrane helix (Transmembrane helix 4). Wolframin has eleven such helices anchoring it in the ER membrane; substitutions inside the bilayer-embedded segments can disrupt helix packing, lipid contacts, and the overall ER topology of the protein. The wild-type residue is rigid/helix-breaking (proline — kinks backbone); the mutant is medium hydrophobic (leucine — branched). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.8743
am_classlikely pathogenic
InterpretationLikely pathogenic (threshold 0.564)

DynaMut2

FieldValue
ΔΔG (kcal/mol)-0.58 (Destabilising)
Job ID178092109516
Result URLhttps://biosig.lab.uq.edu.au/dynamut2/results_prediction/178092109516

Clinical Evidence

FieldValue
ClassificationUncertain significance
Review statuscriteria provided, multiple submitters, no conflicts
Last evaluated2024/11/16 00:00
InheritanceAutosomal dominant pattern indicated by associated DFNA6/14/38 (WFS1 hearing loss 6).
WFS1 variant landscapeP404L is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)
  • Wolfram syndrome 1
  • Cataract 41
  • Autosomal dominant nonsyndromic hearing loss 6
  • Type 2 diabetes mellitus
  • Wolfram-like syndrome

Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 3/4 — Most Druggable

<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=0.58 < 2 kcal/mol (fold intact) + AlphaMissense 0.874 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=0.58 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.874. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • P404L_molstar_viewer.html — interactive 3D viewer (auto-highlights position 404 with ball-and-stick + neighbors within 5Å)
  • P404L_variant_card.md — this card (source of truth)
  • P404L_variant_card.html — styled printable card
  • P404L_dynamut2_summary.html — clean offline DynaMut2 result card
  • dynamut2_result.json — structured result data
  • dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
  • P404L_wildtype_interactions.pse / P404L_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the P404L PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download P404L PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.